Related Experiment Video
Updated: May 16, 2026

Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET
Published on: January 27, 2012
FAK regulates Cdk2 in EGF-stimulated primary cultures of hepatocytes
Liv Ingrid Flinder1, Lene Wierød, Carola M Rosseland
1Laboratory for Toxicopathology, Institute of Pathology, Oslo University Hospital, University of Oslo, Oslo, Norway.
Abstract:
In this study, we report a novel role of FAK as a regulator of Cdk2 in anchorage-dependent primary cultured hepatocytes. In response to EGF, we found that S-phase entry was reduced upon FAK inhibition. This correlated with decreased protein expression and nuclear accumulation of the G1/S-phase regulator Cdk2. Further, nuclear accumulation of the Cdk2 partner cyclinE, was reduced, but not its protein level. Also, protein levels of Cdk2 were inversely linked with increased expression of the Cdk2 inhibitor p27, known to be degraded in a Cdk2-dependent manner. Also, cyclinD1 was regulated by FAK, but to a lesser extent than Cdk2. To assess the mechanism in which FAK mediates Cdk2-regulation, FAK mutants were used: FAKY397F, mutated at its integrin-regulated site, and two others mutated at docking sites for Grb2-ERK-activation (FAKY925F) and for p130Cas-Rac1-activation (FAKY861F). All three sites were central for EGF-induced ERK-activity and Cdk2 expression. In addition, FAK was important for HGF-mediated proliferation, suggesting a general mechanism for anchorage-dependent growth. Moreover, growth factor-induced cell spreading, but not survival, required FAK. Hence, integrins and growth factors cooperate in anchorage-dependent signaling events leading to proliferation and motility. In conclusion, our data suggest that FAK acts as a central coordinator of integrin and growth factor-mediated S-phase entry by its ability to regulate Cdk2.
Insights
Focal adhesion kinase (FAK) regulates cell cycle entry by controlling Cdk2 levels in hepatocytes. This finding reveals FAK
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cellular processes like proliferation and motility depend on anchorage-dependent signaling.
- Focal adhesion kinase (FAK) plays a role in cell signaling pathways.
- Cyclin-dependent kinase 2 (Cdk2) is crucial for cell cycle progression.
Purpose of the Study:
- To investigate the novel role of FAK in regulating Cdk2 in primary cultured hepatocytes.
- To elucidate the mechanism by which FAK mediates Cdk2 regulation in response to growth factors.
Main Methods:
- Utilized FAK inhibition and specific FAK mutants (FAKY397F, FAKY925F, FAKY861F) in primary cultured hepatocytes.
- Assessed S-phase entry, protein expression, and nuclear accumulation of cell cycle regulators (Cdk2, cyclin E, p27, cyclin D1).
- Investigated the impact of FAK on epidermal growth factor (EGF) and hepatocyte growth factor (HGF) signaling, including cell spreading and survival.
Main Results:
- FAK inhibition reduced S-phase entry, Cdk2 expression, and nuclear accumulation in response to EGF.
- FAK regulates Cdk2 levels, influencing the expression of its inhibitor p27.
- Specific FAK phosphorylation sites are critical for EGF-induced ERK activity and Cdk2 expression, and FAK is essential for HGF-mediated proliferation and growth factor-induced cell spreading.
Conclusions:
- FAK acts as a central coordinator of integrin and growth factor signaling for S-phase entry.
- FAK regulates Cdk2, a key G1/S-phase transition regulator.
- Integrins and growth factors cooperate through FAK in anchorage-dependent signaling pathways that control proliferation and motility.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Mitogens and the Cell Cycle
Negative Regulator Molecules